Glen Eagle Advisors, LLC Sanofi Transaction History

Glen Eagle Advisors, LLC

$650 Billion
Q2 2025

A detailed history of Glen Eagle Advisors, LLC transactions in Sanofi stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 79 shares of SNY stock, worth $3,961. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 79 -0.0%

Holding current value

$3,961

Previous $4.38 Million 12.9%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$45.39 - $50.36 $58,371 - $64,762	-1,286 Reduced 94.21%	79 $3.83 Million
Q1 2023 Aug 13, 2024	SELL	$45.86 - $54.45 $1,605 - $1,905	-35 Closed	0 $0
Q4 2022 Aug 13, 2024	BUY	$38.86 - $48.55 $1,360 - $1,699	35 New	35 $1.7 Million
Q1 2022 Aug 13, 2024	SELL	$48.48 - $53.65 $4,848 - $5,365	-100 Closed	0 $0
Q4 2021 Aug 13, 2024	SELL	$47.07 - $52.35 $38,362 - $42,665	-815 Reduced 89.07%	100 $5.01 Million
Q2 2021 Aug 13, 2024	SELL	$49.36 - $54.25 $34,552 - $37,975	-700 Reduced 43.34%	915 $48.2 Million
Q4 2020 Aug 13, 2024	BUY	$45.3 - $51.62 $73,159 - $83,366	1,615 New	1,615 $78.5 Million
Q2 2020 Aug 13, 2024	BUY	$42.91 - $52.5 $35,186 - $43,050	820 Added 50.0%	2,460 $126 Million
Q1 2019 Aug 13, 2024	BUY	$40.83 - $45.43 $66,961 - $74,505	1,640 New	1,640 $72.6 Million
Q2 2018 Aug 13, 2024	SELL	$37.63 - $41.22 $1.07 Million - $1.17 Million	-28,333 Reduced 95.4%	1,365 $54.6 Million
Q1 2018 Aug 14, 2024	BUY	$38.98 - $45.76 $53,207 - $62,462	1,365 New	1,365 $54.7 Million
Q1 2018 Aug 13, 2024	BUY	$38.98 - $45.76 $1.12 Million - $1.32 Million	28,783 Added 3145.68%	29,698 $54.7 Million
Q3 2017 Aug 13, 2024	BUY	$47.04 - $50.34 $43,041 - $46,061	915 New	915 $45.6 Million
Q2 2017 Aug 12, 2024	BUY	N/A	25 Added 3.57%	725 $34.7 Million
Q4 2016 Aug 12, 2024	BUY	N/A	700	700 $28.3 Million

Others Institutions Holding SNY

# of Institutions

831

Shares Held

260M

Call Options Held

1.75M

Put Options Held

1.6M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $126B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Account

Glen Eagle Advisors, LLC Sanofi Transaction History